Skip to main content

Research Repository

Advanced Search

Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app

Louca, Panayiotis; Murray, Benjamin; Klaser, Kerstin; Graham, Mark S.; Mazidi, Mohsen; Leeming, Emily R.; Thompson, Ellen; Bowyer, Ruth; Drew, David A.; Nguyen, Long H.; Merino, Jordi; Gomez, Maria; Mompeo, Olatz; Costeira, Ricardo; Sudre, Carole H.; Gibson, Rachel; Steves, Claire J.; Wolf, Jonathan; Franks, Paul W.; Ourselin, Sebastien; Chan, Andrew T.; Berry, Sarah E.; Valdes, Ana M.; Calder, Philip C.; Spector, Tim D.; Menni, Cristina

Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app Thumbnail


Authors

Panayiotis Louca

Benjamin Murray

Kerstin Klaser

Mark S. Graham

Mohsen Mazidi

Emily R. Leeming

Ellen Thompson

Ruth Bowyer

David A. Drew

Long H. Nguyen

Jordi Merino

Maria Gomez

Olatz Mompeo

Ricardo Costeira

Carole H. Sudre

Rachel Gibson

Claire J. Steves

Jonathan Wolf

Paul W. Franks

Sebastien Ourselin

Andrew T. Chan

Sarah E. Berry

Philip C. Calder

Tim D. Spector

Cristina Menni



Abstract

Objectives Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific evidence to support such a role is lacking. We investigated whether users of the COVID-19 Symptom Study app who regularly took dietary supplements were less likely to test positive for SARS-CoV-2 infection.

Design App-based community survey.

Setting 445?850 subscribers of an app that was launched to enable self-reported information related to SARS-CoV-2 infection for use in the general population in the UK (n=372?720), the USA (n=45?757) and Sweden (n=27?373).

Main exposure Self-reported regular dietary supplement usage (constant use during previous 3 months) in the first waves of the pandemic up to 31 July 2020.

Main outcome measures SARS-CoV-2 infection confirmed by viral RNA reverse transcriptase PCR test or serology test before 31 July 2020.

Results In 372?720 UK participants (175?652 supplement users and 197?068 non-users), those taking probiotics, omega-3 fatty acids, multivitamins or vitamin D had a lower risk of SARS-CoV-2 infection by 14% (95% CI (8% to 19%)), 12% (95% CI (8% to 16%)), 13% (95% CI (10% to 16%)) and 9% (95% CI (6% to 12%)), respectively, after adjusting for potential confounders. No effect was observed for those taking vitamin C, zinc or garlic supplements. On stratification by sex, age and body mass index (BMI), the protective associations in individuals taking probiotics, omega-3 fatty acids, multivitamins and vitamin D were observed in females across all ages and BMI groups, but were not seen in men. The same overall pattern of association was observed in both the US and Swedish cohorts.

Conclusion In women, we observed a modest but significant association between use of probiotics, omega-3 fatty acid, multivitamin or vitamin D supplements and lower risk of testing positive for SARS-CoV-2. We found no clear benefits for men nor any effect of vitamin C, garlic or zinc. Randomised controlled trials are required to confirm these observational findings before any therapeutic recommendations can be made.

Journal Article Type Article
Acceptance Date Mar 4, 2021
Online Publication Date Apr 19, 2021
Publication Date 2021-06
Deposit Date May 9, 2021
Publicly Available Date May 18, 2021
Journal BMJ Nutrition, Prevention & Health
Print ISSN 2516-5542
Electronic ISSN 2516-5542
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 4
Issue 1
Article Number e000250
DOI https://doi.org/10.1136/bmjnph-2021-000250
Public URL https://nottingham-repository.worktribe.com/output/5493608
Publisher URL https://nutrition.bmj.com/content/4/1/149

Files





You might also like



Downloadable Citations